media – Page 660 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Cardinal buys Medtronic’s Patient Recovery business for $6.1bn

Cardinal Health has concluded the purchase of Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business from Medtronic for a total of $6.1bn.
- Source: Medicaldevices-network.com
- 499
- August 1, 2017
Company Insight Market Views patient care
New hepatitis C therapies approved in Europe

Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.
- Source: pharmatimes
- 449
- August 1, 2017
hepatitis inhibitor New Approvals
Plexus TG and Codonics to integrate anaesthesia safety technology

Medication management systems provider Plexus Technology Group (TG) is set to integrate its anaesthesia information management system (AIMS) with medical imaging firm Codonics’ medication safety technology Safe Label System (SLS) for an improved anaesthesia process.
- Source: Medicaldevices-network.com
- 376
- August 1, 2017
anaesthesia Company Insight
Echemi Pharma Forum , A Face-to-Face Meeting in Pharma Asia

Pharma Asia 2017 Pharma Asia is a 3 day event being held from 22nd August to the 24th August 2017 at the Karachi Expo Center in Karachi, Pakistan. This event showcases products like providing investors with a definite outlook of the regional pharmaceutical industry and an opportunity to meet their prospective counterparts and business partners etc. in the Medical & Pharmaceutical industry. Echemi Pharma Forum: From August 22 to 24, Echemi will attend Pharma Asia exhibition, and will take other three Chinese companies to this exhibition. On one side, for visitors, this is a good chance for them to know suppliers and choose their needs directly. On the other side, for suppliers, this is an opportunity to show their products and let more people know their companies. During exhibition period, Echemi will hold “Pharma Forum & Procurement Conference”, which is a face-to-face meeting for suppliers and buyers. There will be ...
- Source: Echemi
- 538
- August 1, 2017
Echemi Exhibitions & Activities ZT League Chemical
Countdown！Ddu to attend the America AACC

The 69th Annual Scientific Meeting and Clinical Lab Exposition (AACC) will be held in Orlando, USA from August 1st to August 3rd, 2017.
- Source: Ddu
- 671
- July 31, 2017
AACC Exhibitions & Activities medical device
AZ, Merck link to develop and commercialise cancer drugs

AstraZeneca and Merck & Co have announced a global strategic oncology collaboration to co-develop and co-commercialise the former’s Lynparza and selumetinib for multiple cancer types.
- Source: pharmatimes
- 501
- July 31, 2017
cancer Lynparza Market Views Researches therapy
EU approves CV benefit claim for Novo’s Victoza

Novo Nordisk’s diabetes drug Victoza is now approved in Europe as the only GLP-1 analogue with a label including prevention of cardiovascular events.
- Source: pharmatimes
- 444
- July 31, 2017
cardiovascular Company Insight diabetes New Approvals
Medtronic launches new MRI cardiac therapy defibrillators

Medtronic’s Canadian subsidiary has launched its new magnetic resonance imaging (MRI) conditional cardiac resynchronisation therapy defibrillators (CRT-Ds)
- Source: Medicaldevices-network.com
- 523
- July 31, 2017
cardiac Company Insight heart MRI
EU OKs first-line use of AZ’ Faslodex

EU regulators are permitting the use of AstraZeneca’s breast cancer drug Faslodex at an earlier stage of the treatment pathway in patients with certain forms of the disease.
- Source: pharmatimes
- 791
- July 28, 2017
breast cancer EU inhibitor New Approvals
Takeda and BioSurfaces to develop new medical devices for GI indications

Japan's Takeda Pharmaceutical Company has signed an agreement with US-based nanotechnology provider BioSurfaces to develop new therapeutic devices to treat gastrointestinal (GI) diseases.
- Source: Medicaldevice-network
- 433
- July 28, 2017
Company Insight gastrointestinal nanofibrous New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.